Long-term efficacy and tolerability of adjunctive brivaracetam in adults with focal to bilateral tonic-clonic (secondary generalized) seizures: Post hoc pooled analysis

Long-term safety, efficacy, and quality of life during adjunctive brivaracetam treatment in patients with uncontrolled epilepsy: An open-label follow-up trial

(2021) Manuel Toledo et al.   EPILEPSY & BEHAVIOR

Time course of 75%–100% efficacy response of adjunctive brivaracetam

(2020) Pavel Klein et al.   ACTA NEUROLOGICA SCANDINAVICA

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial

(2020) Terence J. O’Brien et al.   EPILEPSIA

Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: second interim analysis of 6-month data from a prospective observational study in Europe

(2020) Bernhard J. Steinhoff et al.   EPILEPSY RESEARCH

Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: post-hoc analysis of a randomized, placebo-controlled trial

(2020) Pavel Klein et al.   EPILEPSY RESEARCH

Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht–Lundborg disease: An open-label, long-term follow-up trial

(2020) Elinor Ben-Menachem et al.   EPILEPSY RESEARCH

Risks and predictive biomarkers of sudden unexpected death in epilepsy patient

(2019) Philippe Ryvlin et al.   CURRENT OPINION IN NEUROLOGY

Clinical risk factors in SUDEP

(2019) Olafur Sveinsson et al.   NEUROLOGY

Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology

(2017) Robert S. Fisher et al.   EPILEPSIA

Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy

(2017) Baibing Chen et al.   EPILEPSY & BEHAVIOR

Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors

(2017) Cynthia Harden et al.   NEUROLOGY

Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures

(2016) Manuel Toledo et al.   EPILEPSIA

Time to onset of sustained ≥50% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment

(2016) Pavel Klein et al.   EPILEPSIA

PatientsLikeMe® Online Epilepsy Community: Patient characteristics and predictors of poor health-related quality of life

(2016) Christine de la Loge et al.   EPILEPSY & BEHAVIOR

Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies

(2016) Brian D. Moseley et al.   EPILEPSY RESEARCH

A reappraisal of mortality after epilepsy surgery

(2016) Michael R. Sperling et al.   NEUROLOGY

A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures

(2015) Pavel Klein et al.   EPILEPSIA

Seizure frequency and severity: How really important are they for the quality of life of patients with refractory epilepsy

(2014) EkaterinaIvanova Viteva   Annals of Indian Academy of Neurology

The consequences of refractory epilepsy and its treatment

(2014) Kenneth D. Laxer et al.   EPILEPSY & BEHAVIOR

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial

(2013) Victor Biton et al.   EPILEPSIA

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial

(2013) Philippe Ryvlin et al.   EPILEPSIA

Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures

(2012) Simon Borghs et al.   EPILEPSY & BEHAVIOR

Predictors of health-related quality of life and costs in adults with epilepsy: A systematic review

(2011) Rod S. Taylor et al.   EPILEPSIA

Combined analysis of risk factors for SUDEP

(2011) Dale C. Hesdorffer et al.   EPILEPSIA

Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties

(2011) Michel Gillard et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Sudden unexpected death in epilepsy

(2011) Simon Shorvon et al.   LANCET

Abbreviated report of the NIH/NINDS workshop on sudden unexpected death in epilepsy

(2011) L. J. Hirsch et al.   NEUROLOGY

Sudden, Unexpected Death in Epilepsy

(2011) Orrin Devinsky   NEW ENGLAND JOURNAL OF MEDICINE

Open label extension studies and patient selection biases

(2010) Karla Hemming et al.   JOURNAL OF EVALUATION IN CLINICAL PRACTICE

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A

(2008) A Matagne et al.   BRITISH JOURNAL OF PHARMACOLOGY

Reporting and analysis of open-label extension studies of anti-epileptic drugs

(2008) M.J. Maguire et al.   EPILEPSY RESEARCH